10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping

June 10, 2021 at 8:01 AM EDTPDF Version Fueling Discovery in Preserved Tissue Samples to Advance Clinical Translational Research PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay. The offering gives researchers access to the... Read more

Thermo Fisher Scientific Announces Agreement with Advanced Electrophoresis Solutions Ltd to Accelerate Therapeutic Development through Cutting-Edge Protein Analysis

Thermo Fisher Scientific Announces Agreement with Advanced Electrophoresis Solutions Ltd to Accelerate Therapeutic Development through Cutting-Edge Protein Analysis SAN JOSE, Calif., June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Advanced Electrophoresis Solutions Ltd (AES), specialists in protein imaging technologies, today announced an agreement to combine essential protein separation techniques... Read more

Bruker Launches CE-IVD Quantitative Coronavirus Mid-Plex PCR Assay with Mutation Detection for Routine Variant Differentiation

FluoroType® SARS-CoV-2 varID Q is a novel LiquidArray® mid-plex PCR panel Detection of selected SARS-CoV-2 mutations enables differentiation of major viral variants, or strains, without the costs and delays of selective NGS for variant epidemiology Quantification of viral load provides indication of infectivity and of stage of COVID infection Validated with nasopharyngeal swabs and oropharyngeal... Read more

Agilent Announces New SureSelect Human All Exon V8

Design provides comprehensive content and flexible exome options SANTA CLARA, Calif., June 02, 2021  Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein-coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture... Read more

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis

SAN DIEGO–(BUSINESS WIRE)–Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities (ID) and/or developmental disorders (DD) in routine care. The study, run by the Belgian Resolve Rare Diseases group (BeSolveRD), will also assess the health economic impact of WGS... Read more

Thermo Fisher Scientific's TaqPath COVID-19 CE-IVD RT-PCR Kit Now Available for the Incoming International Travel Quarantine Protocol Testing in the United Kingdom

Thermo Fisher Scientific’s TaqPath COVID-19 CE-IVD RT-PCR Kit Now Available for the Incoming International Travel Quarantine Protocol Testing in the United Kingdom Highly Sensitive and Accurate COVID-19 PCR Testing Kits Available to Increase Testing Availability INCHINNAN, Scotland, May 27, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that its TaqPath... Read more

Pacific Biosciences Further Expands Leadership Team with Appointment of Dr. Catherine Ball to Newly Created Position of Senior Vice President of Research

MENLO PARK, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced the appointment of three new hires to its growing team. Dr. Catherine Ball joins the company as Senior Vice President of Research, Kathleen Lynch joins as Head of Global... Read more

Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it is appointing Susan Tousi as Chief Commercial Officer (CCO), and Dr. Alex Aravanis as Chief Technology Officer (CTO), Head of Research and Product Development. “We’re fortunate to have Susan and Alex, two of the strongest leaders in the genomics industry, take on these large, important... Read more

PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC

Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment WALTHAM, Mass.–(BUSINESS WIRE)–May 17, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Immunodiagnostic Systems Holdings PLC (LSE: IHS) (“IDS”) are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approximately $155 million (£110 Million).... Read more

Court of Appeals for the Federal Circuit, US, upholds jury decision to invalidate certain PacBio patents

Tue 11th May 2021 Today the Court of Appeals for the Federal Circuit issued a unanimous Precedential Opinion and Judgment affirming the jury’s March 2020 verdict in the PacBio v. Oxford Nanopore case, that invalidated a number of PacBio patents.  This has been a long running dispute in which Oxford Nanopore has repeatedly prevailed.  In... Read more